VeriChip's IPO: Losses Ahead for New Implant System [View article]
and for the record, my entire article is far from false and made of lies. CHIP has a business plan that will not work. It really is that simple. Frankly I don't have the power or the inclination to manipulate stocks. You're giving me far, far too much credit there. I've not had a position in Verichip nor ADSX and I've no plans on ever having one long or short. I will state emphatically this CHIP ipo is one of the worst I've seen since Vonage, which I also panned.
Good luck to you. You should be careful with your accusations and threats however.
VeriChip's IPO: Losses Ahead for New Implant System [View article]
Marc, adsx comment in piece is a typo...should read CHIP had under $30 million in revenues. My aplogies there. you may want to dig into 2006 compensation. you listed 2005, which again is pretty darned steep for such a lousy operation as CHIP --- 2006's compensation for making the switch from ADSX to CHIP is beyond outrageous.
I've no position in CHIP long or short. CHIP is one of the worst ipos I've seen. They've a faulty business plan and they seem intent on throwing lots of money at that business plan.
I call 'em like I see 'em and CHIP's implantable business segment is DOA. first of all without 3rd party payer reimbursement, the business plan itself is doomed regardless of anything else.
they've two decent business lines,,,,however the seem set on spending heavily on this implantable chip segment, which means steep losses going forward.
VeriChip's IPO: Losses Ahead for New Implant System [View article]
Good luck to you. You should be careful with your accusations and threats however.
VeriChip's IPO: Losses Ahead for New Implant System [View article]
I've no position in CHIP long or short. CHIP is one of the worst ipos I've seen. They've a faulty business plan and they seem intent on throwing lots of money at that business plan.
I call 'em like I see 'em and CHIP's implantable business segment is DOA. first of all without 3rd party payer reimbursement, the business plan itself is doomed regardless of anything else.
they've two decent business lines,,,,however the seem set on spending heavily on this implantable chip segment, which means steep losses going forward.